198 related articles for article (PubMed ID: 36199268)
1. CRISPR-Cas system manipulating nanoparticles signal transduction for cancer diagnosis.
Guo Y; Guo L; Su Y; Xiong Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1851. PubMed ID: 36199268
[TBL] [Abstract][Full Text] [Related]
2. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
Fu R; Xianyu Y
Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
[TBL] [Abstract][Full Text] [Related]
3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
Ahmed MZ; Badani P; Reddy R; Mishra G
J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
[TBL] [Abstract][Full Text] [Related]
4. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
[TBL] [Abstract][Full Text] [Related]
5. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
Zhang L; Jiang H; Zhu Z; Liu J; Li B
Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas-Based In Vitro Diagnostic Platforms for Cancer Biomarker Detection.
Gong S; Zhang S; Lu F; Pan W; Li N; Tang B
Anal Chem; 2021 Sep; 93(35):11899-11909. PubMed ID: 34427091
[TBL] [Abstract][Full Text] [Related]
7. The design strategies for CRISPR-based biosensing: Target recognition, signal conversion, and signal amplification.
Yin Y; Wen J; Wen M; Fu X; Ke G; Zhang XB
Biosens Bioelectron; 2024 Feb; 246():115839. PubMed ID: 38042054
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
[TBL] [Abstract][Full Text] [Related]
9. Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing.
Bao M; Chen Q; Xu Z; Jensen EC; Liu C; Waitkus JT; Yuan X; He Q; Qin P; Du K
ACS Sens; 2021 Jul; 6(7):2497-2522. PubMed ID: 34143608
[TBL] [Abstract][Full Text] [Related]
10. Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids.
Bonini A; Poma N; Vivaldi F; Kirchhain A; Salvo P; Bottai D; Tavanti A; Di Francesco F
J Pharm Biomed Anal; 2021 Jan; 192():113645. PubMed ID: 33039910
[TBL] [Abstract][Full Text] [Related]
11. The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection.
He Y; Yan W; Long L; Dong L; Ma Y; Li C; Xie Y; Liu N; Xing Z; Xia W; Li F
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107608
[TBL] [Abstract][Full Text] [Related]
12. Nanozyme-assisted amplification-free CRISPR/Cas system realizes visual detection.
Zhang Y; Yu W; Wang M; Zhang L; Li P
Front Bioeng Biotechnol; 2023; 11():1327498. PubMed ID: 38249803
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas12a-based dual amplified biosensing system for sensitive and rapid detection of polynucleotide kinase/phosphatase.
Wang DX; Wang J; Du YC; Ma JY; Wang SY; Tang AN; Kong DM
Biosens Bioelectron; 2020 Nov; 168():112556. PubMed ID: 32890931
[TBL] [Abstract][Full Text] [Related]
14. [Application of CRISPR/Cas systems in the nucleic acid detection of pathogens: a review].
Li M; Qin Z; Yin K; Zheng B
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Feb; 35(1):98-103. PubMed ID: 36974023
[TBL] [Abstract][Full Text] [Related]
15. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
[TBL] [Abstract][Full Text] [Related]
16. An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.
Roueinfar M; Templeton HN; Sheng JA; Hong KL
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164379
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas-Integrated LAMP.
Atçeken N; Yigci D; Ozdalgic B; Tasoglu S
Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421156
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas-powered nanobiosensors for diagnostics.
Phan QA; Truong LB; Medina-Cruz D; Dincer C; Mostafavi E
Biosens Bioelectron; 2022 Feb; 197():113732. PubMed ID: 34741959
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A review.
Habimana JD; Huang R; Muhoza B; Kalisa YN; Han X; Deng W; Li Z
Biosens Bioelectron; 2022 May; 203():114033. PubMed ID: 35131696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
